https://www.marketscreener.com/quote/stock/BLUEBIRD-BIO-INC-13430435/news/bluebird-bio-Announces-Updated-Clinical-Results-from-Ongoing-Phase-1-Multicenter-Study-of-LentiGlo-25644759/?utm_source=telegram&utm_medium=social&utm_campaign=share